Globus Medical (GMED) Tops Q4 EPS by 5c

Globus Medical (NYSE: GMED) reported Q4 EPS of $0.30, $0.05 better than the analyst estimate of $0.25. Revenue for the quarter came in at $128.8 million versus the consensus estimate of $127.77 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• Sharon AI secures six-year compute deal with NVIDIA for Australia deployment
• Barclays Downgrades Travelers (TRV) to Underweight